[Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19].

M V Zhuravleva Vladimir P Chulanov J V Gagarina E A Shabalina

Published in: Terapevticheskii arkhiv (2023)

Pre-exposure prophylaxis of COVID-19 with combination of tixagevimab and cilgavimab is economically feasible and may be recommended for wide use in Russian healthcare system.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus